Decoy Therapeutics (DCOY)
4.95
+0.03 (0.61%)
Latest Headlines
Form EFFECT Decoy Therapeutics Inc.
July 20, 2026 6:02 AM - SEC Filing
Form 424B3 Decoy Therapeutics Inc.
July 17, 2026 5:08 PM - SEC Filing
Form 8-K Decoy Therapeutics Inc. For: Jul 14
July 15, 2026 5:14 PM - SEC Filing
Decoy Therapeutics elects Moderna executive to its board
July 15, 2026 9:25 AM - StreetInsider
Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors
July 15, 2026 9:25 AM - PR NewsWire
Decoy Therapeutics (DCOY) files for 3.77M share offering by selling stockholders
July 10, 2026 4:28 PM - StreetInsider
Form S-1 Decoy Therapeutics Inc.
July 10, 2026 4:26 PM - SEC Filing
4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones
June 29, 2026 9:51 AM - StreetInsider
Form 8-K Decoy Therapeutics Inc. For: Jun 26
June 29, 2026 6:04 AM - SEC Filing
Decoy Therapeutics announces up to $21M private placement
June 26, 2026 8:12 PM - StreetInsider
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 26, 2026 8:12 PM - PR NewsWire
Form EFFECT Decoy Therapeutics Inc.
June 25, 2026 6:03 AM - SEC Filing
Decoy Therapeutics (DCOY) files for 808K share offering by selling stockholders
June 15, 2026 6:13 AM - StreetInsider
Form S-1 Decoy Therapeutics Inc.
June 15, 2026 6:11 AM - SEC Filing
Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London
June 8, 2026 8:00 AM - PR NewsWire
Form RW Decoy Therapeutics Inc.
June 5, 2026 4:33 PM - SEC Filing
Form DEFA14A Decoy Therapeutics Inc.
June 4, 2026 8:30 AM - SEC Filing
Form DEF 14A Decoy Therapeutics Inc. For: Jun 04
June 4, 2026 8:27 AM - SEC Filing
Decoy Therapeutics nominates Patricia Gauthier for board election
June 3, 2026 8:01 AM - StreetInsider
Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors
June 3, 2026 8:00 AM - PR NewsWire
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
June 1, 2026 7:00 AM - PR NewsWire
Decoy Therapeutics names MIT professor as advisory board chair
May 26, 2026 8:15 AM - StreetInsider
Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board
May 26, 2026 8:15 AM - PR NewsWire
Form 8-K Decoy Therapeutics Inc. For: May 19
May 19, 2026 4:07 PM - SEC Filing
Form 10-Q Decoy Therapeutics Inc. For: Mar 31
May 8, 2026 4:46 PM - SEC Filing
Form 10-K/A Decoy Therapeutics Inc. For: Dec 31
April 30, 2026 1:03 PM - SEC Filing
Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston
April 27, 2026 8:45 AM - PR NewsWire
Full Article List